Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer

Podobne knjige/članki

• Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib
  od: Johnson, Melissa L., et al.
  Izdano: (2011)
• Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
  od: Oxnard, Geoffrey R., et al.
  Izdano: (2011)
• A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors
  od: Janjigian, Yelena Y, et al.
  Izdano: (2009)
• A Phase 2 Study of Weekly Albumin-Bound Paclitaxel (Abraxane(®)) Given as a Two-Hour Infusion
  od: Paik, Paul K., et al.
  Izdano: (2011)
• KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
  od: Pao, William, et al.
  Izdano: (2005)